Abortion Pill Use Is Surging Post-Dobbs. Now It’s Under Threat
The Texas ruling also conflicted with one made the same day by a judge in Washington state, directing US authorities to preserve mifepristone access in 17 states and the District of Columbia.Meanwhile, new suits have been filed in an effort to maintain mifepristone access, including a pair of unrelated suits challenging state restrictions in North Carolina and West Virginia. GenBioPro, the primary US manufacturer of generic mifepristone, is the plaintiff in the West Virginia suit, and is also suing the FDA, arguing that…